DEAR HEALTH (CONT’D)
20/09/22 -"Over the last three years, AlphaValue has been on a mission to call Health stocks expensive. That segment excludes Pharmas. The sector is down 30%, of which 7% over the last week. That still leaves ..."
Pages
60
Language
English
Published on
20/09/22
You may also be interested by these reports :
29/07/26
Our opinion is shifting back to Sell after the poor profitability figures disclosed by M6 yesterday prompting us to revise our forecasts for the ...
28/07/26
M6 delivered mixed Q2 results with strong top-line growth and a bottom-line decline linked to the World Cup. We fail to see a durable improvement in ...
28/07/26
Total Group revenue increased by 1.5% yoy and lfl in Q2, a positive development following a 0.4% decline in the previous quarter. Group EBIT, ...
24/07/26
TF1 has just released good Q2 results, surprising on the upside on profitability and confirming its objectives. We continue to foresee a difficult ...